Accuray Incorporated (0H8I.L)
USD 1.91
(-2.54%)
USD 1.91
(-2.54%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 172.15 Million USD | 2.79% |
| 2022 | 205.03 Million USD | 2.78% |
| 2021 | 199.49 Million USD | 0.04% |
| 2020 | 199.4 Million USD | -10.06% |
| 2019 | 221.7 Million USD | 38.7% |
| 2018 | 159.84 Million USD | 21.95% |
| 2017 | 131.07 Million USD | -20.35% |
| 2016 | 164.57 Million USD | -21.79% |
| 2015 | 210.41 Million USD | 5.39% |
| 2014 | 199.65 Million USD | 2.07% |
| 2013 | 195.61 Million USD | -1.59% |
| 2012 | 198.76 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 FY | 210.74 Million USD | 2.79% |
| 2023 Q1 | 204.9 Million USD | -0.06% |
| 2023 Q2 | 202.22 Million USD | -1.31% |
| 2023 Q3 | 206.99 Million USD | 2.36% |
| 2023 Q4 | 172.15 Million USD | 1.82% |
| 2022 Q3 | 205.02 Million USD | -1.14% |
| 2022 Q4 | 205.03 Million USD | 0.01% |
| 2022 Q1 | 205.31 Million USD | 2.92% |
| 2022 Q2 | 207.38 Million USD | 1.01% |
| 2022 FY | 205.03 Million USD | 2.78% |
| 2021 Q3 | 201.52 Million USD | -1.27% |
| 2021 FY | 199.49 Million USD | 0.04% |
| 2021 Q1 | 221.95 Million USD | 11.31% |
| 2021 Q2 | 204.11 Million USD | -8.04% |
| 2021 Q4 | 199.49 Million USD | -1.01% |
| 2020 Q4 | 199.4 Million USD | -1.24% |
| 2020 Q2 | 201.57 Million USD | -0.35% |
| 2020 Q1 | 202.27 Million USD | -5.25% |
| 2020 Q3 | 201.92 Million USD | 0.17% |
| 2020 FY | 199.4 Million USD | -10.06% |
| 2019 Q2 | 211.03 Million USD | -1.39% |
| 2019 FY | 221.7 Million USD | 38.7% |
| 2019 Q4 | 213.48 Million USD | -1.41% |
| 2019 Q3 | 216.54 Million USD | 2.61% |
| 2019 Q1 | 214 Million USD | 33.89% |
| 2018 Q2 | 136.82 Million USD | 6.13% |
| 2018 Q1 | 128.92 Million USD | -1.64% |
| 2018 FY | 159.84 Million USD | 21.95% |
| 2018 Q4 | 159.84 Million USD | 9.51% |
| 2018 Q3 | 145.95 Million USD | 6.68% |
| 2017 Q1 | 158.02 Million USD | -3.98% |
| 2017 Q4 | 131.07 Million USD | -2.42% |
| 2017 FY | 131.07 Million USD | -20.35% |
| 2017 Q3 | 134.32 Million USD | -20.93% |
| 2017 Q2 | 169.87 Million USD | 7.5% |
| 2016 Q1 | 175.02 Million USD | -16.82% |
| 2016 Q4 | 164.57 Million USD | -3.21% |
| 2016 FY | 164.57 Million USD | -21.79% |
| 2016 Q3 | 170.03 Million USD | -0.08% |
| 2016 Q2 | 170.16 Million USD | -2.77% |
| 2015 FY | 210.41 Million USD | 5.39% |
| 2015 Q4 | 210.41 Million USD | 0.35% |
| 2015 Q3 | 209.67 Million USD | 1.43% |
| 2015 Q2 | 206.72 Million USD | 0.95% |
| 2015 Q1 | 204.77 Million USD | 2.56% |
| 2014 Q1 | 197.37 Million USD | 0.9% |
| 2014 Q2 | 199.15 Million USD | 0.9% |
| 2014 Q4 | 199.65 Million USD | -0.66% |
| 2014 Q3 | 200.98 Million USD | 0.92% |
| 2014 FY | 199.65 Million USD | 2.07% |
| 2013 Q2 | 201.08 Million USD | 0.58% |
| 2013 Q3 | 202.28 Million USD | 0.6% |
| 2013 Q4 | 195.61 Million USD | -3.3% |
| 2013 FY | 195.61 Million USD | -1.59% |
| 2013 Q1 | 199.91 Million USD | 0.58% |
| 2012 Q4 | 198.76 Million USD | 0.56% |
| 2012 FY | 198.76 Million USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | 197.65 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -1336.669% |
| Align Technology, Inc. | 96.96 Million USD | -77.539% |
| Elevance Health Inc. | 25.12 Billion USD | 99.315% |
| AxoGen, Inc. | 69.29 Million USD | -148.45% |
| Boston Scientific Corporation | 9.09 Billion USD | 98.108% |
| CVS Health Corporation | 79.38 Billion USD | 99.783% |
| Cardinal Health, Inc. | 5.6 Billion USD | 96.931% |
| Centene Corporation | 17.69 Billion USD | 99.027% |
| DaVita Inc. | 11.11 Billion USD | 98.451% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 99.589% |
| Hologic, Inc. | 2.53 Billion USD | 93.208% |
| Humana Inc. | 10.21 Billion USD | 98.314% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | 81.838% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | 97.109% |
| Masimo Corporation | 970 Million USD | 82.252% |
| McKesson Corporation | 5.47 Billion USD | 96.854% |
| Patterson Companies, Inc. | 762.94 Million USD | 77.435% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | 96.794% |
| ResMed Inc. | 873.93 Million USD | 80.301% |
| Henry Schein, Inc. | 2.74 Billion USD | 93.719% |
| Teladoc Health, Inc. | 1.59 Billion USD | 89.188% |
| Universal Health Services, Inc. | 5.36 Billion USD | 96.792% |
| Veeva Systems Inc. | 55.77 Million USD | -208.662% |
| Baxter International Inc. | 14.36 Billion USD | 98.801% |
| Becton, Dickinson and Company | 15.87 Billion USD | 98.916% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -91.71% |
| Danaher Corporation | 19.35 Billion USD | 99.111% |
| Stryker Corporation | 12.99 Billion USD | 98.675% |
| Medtronic plc | 24.96 Billion USD | 99.31% |